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Evolución histórica de las enfermedades 
causadas por micobacterias no pigmentadas 
de crecimiento rápido en un Hospital 
Universitario
RESUMEN 
Introducción. Las micobacterias no pigmentadas de 
crecimiento rápido (MNPCR) son un grupo de organismos 
de interés creciente debido al número cada vez mayor de 
pacientes potenciales y a las dificultades en el tratamiento. 
Sin embargo, el número de estudios que analizan la evolución 
de estos casos a lo largo de un periodo de tiempo largo es 
escaso. 
Material and métodos. Se realizó un estudio 
retrospectivo entre el 1 de enero de 2004 y el 31 de diciembre 
de 2017 para evaluar el significado clínico y los tipos de 
enfermedades causados por MNPCR. Se seleccionaron para ello 
aquellos pacientes con aislamientos de MNPCR, y se revisaron 
las historias clínicas mediante un protocolo predefinido.
Resultados. Se identificaron 59 pacientes (76 muestras) 
con aislamientos de MNPCR, de los cuales 12 presentaron 
enfermedad y uno tuvo un significado dudoso (incluyendo 6 
infecciones respiratorias, 2 infecciones asociadas a catéter, 
1 infección de piel y partes blandas, 1 infección diseminada, 
1 conjuntivitis, 1 infección de prótesis osteoarticular y 1 
mastitis). El 50 % de los aislamientos de Mycobacterium 
chelonae, el 37,5 % de Mycobacterium abscessus y el 
23,33 % de Mycobacterium fortuitum fueron clínicamente 
significativos. Ninguno de los aislamientos de otras especies 
fue significativo. 
Conclusiones. La mayoría de los aislamientos de 
muestras respiratorias resultaron ser contaminantes/
colonizaciones. M. abscessus fue el principal agente etiológico 
en las infecciones respiratorias, mientras que M. chelonae y 
M. fortuitum fueron asociados con mayor frecuencia a otras 
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and the difficulties for a proper treatment in many of them. 
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planktonic type of growth, as resistance to environmental 
aggressions and an increased resistance against disinfectants 
and antibiotics [10].
M. abscessus is one of the most frequently causative 
agents of nontuberculous mycobacterial pulmonary disease, 
often isolated in patients with underlying chronic lung 
diseases, like old tuberculosis scars, silicosis, bullae and other 
lung cavities where NTM can develop a biofilm. In recent times, 
patients with chronic bronchiectasis and cystic fibrosis have 
been found to be a target for NPRGM infections [11-13].
M. chelonae and M. fortuitum are frequently isolated 
in skin and soft tissue infections [14-15]. However, all these 
organisms can be isolated in other different clinical samples as 
a cause of many types of infection. 
Here we report our experience with the diseases caused 
by these organisms isolated in our hospital during a 13-year 
period in order to compare these results with previous studies 
regarding these organisms.
MATERIAL AND METHODS
A retrospective study was performed to evaluate the clinical 
significance of the NPRGM. For this purpose, records dating from 
January 1st 2004 to December 31st 2017 from the mycobacteriology 
laboratory of the clinical microbiology department were reviewed. 
Patients with at least one isolate of NPRGM from clinical samples 
were selected for clinical charts review.
Sample processing and identification of bacterial isolates 
was performed following the internationally accepted 
protocols. The decontamination technique for all samples was 
infecciones, especialmente infecciones de piel y partes blandas 
e infecciones asociadas a dispositivos biomédicos.
Palabras clave: micobacterias no pigmentadas de crecimiento rápido; 
Mycobacterium abscessus; Mycobacterium chelonae; Mycobacterium 
fortuitum; significado clínico; evolución histórica ; epidemiología.
INTRODUCTION
Non-tuberculous mycobacteria (NTM) are a group 
of opportunistic pathogens which are being increasingly 
recognized as a cause of infection [1]. They are also 
environmental organisms that can be found in many different 
ecosystems without public health implications [2].
NTM infections are an emerging phenomenon, mainly 
in the last decade [3]. It has been observed an increasing 
importance of infections caused by these organisms, both 
localized and disseminated, including also outbreaks and 
pseudo-outbreaks [4-5]. Among these, non-pigmented rapidly 
growing mycobacteria (NPRGM) are ubiquitous in nature and 
widely distributed in water, soil and animals [2, 6].
The three most important species of this group, regarding 
their clinical relevance, are Mycobacterium fortuitum, 
Mycobacterium chelonae and Mycobacterium abscessus [7]. 
However, there are many other species capable of causing 
human diseases such as Mycobacterium mucogenicum, 
Mycobacterium immunogenum, Mycobacterium goodii, 
Mycobacterium peregrinum, Mycobacterium phocaium, 
Mycobacterium porcinum, Mycobacterium smegmatis or 
Mycobacterium wolinskyi [7-9]. 
These microorganisms have the ability to form biofilms 
and this gives these organisms many advantages over the 
Figure 1 Number of patients with NPRGM
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Isolated mycobacteria were Mycobacterium fortuitum 
(30 patients), Mycobacterium abscessus (8 patients), 
Mycobacterium mucogenicum (9 patients), Mycobacterium 
chelonae (6 patients), Mycobacterium peregrinum (4 patients), 
Mycobacterium porcinum (1 patient), Mycobacterium 
smegmatis (1 patient) and Mycobacterium arupense (1 
patient) (figure 1). One patient had two different NPRGM in 
two different samples. M. fortuitum was the most frequent 
isolated mycobacterium, with a sharply increase in 2005, 2007 
and 2011. M. abscessus had a significant increase in 2012. M. 
chelonae was the less isolated mycobacterium with only 0 or 
1 isolates per year, except in 2016 when it was isolated three 
times (figure 2).
Most of the samples were sputum and other respiratory 
samples (58 samples) followed by wound exudates and skin 
biopsies (5 samples), urine (3 samples), blood cultures (2 
samples) and several other samples (8 samples).
Clinically significant cases appeared in 12 patients (20.3 
%). One patient was classified as doubtful, and the rest 
of them were non-clinically significant cases. Syndromes 
and treatment of the patients with true or doubtful clinical 
significance are shown in table 1.
The clinical syndromes related to NPRGM include 
respiratory tract infections (6 cases), catheter infections (2 
cases), skin and soft tissue infection (1 case), disseminated 
infection (1 case), conjunctivitis (1 case), prosthetic joint 
infection (1 case) and mastitis (1 case). 
Regarding the clinical relevance of each species, 50% of 
the isolates of M. chelonae, 37.5% of M. abscessus and 23.33% 
of M. fortuitum were clinically significant. None of the isolates 
of other species were significant. 
the N-acetyl-cysteine-NaOH protocol throughout all these 
years. After decontamination, all samples were inoculated onto 
Lowenstein-Jensen and Coletsos solid slants and were inoculated 
also in a liquid medium (MGIT 960 from 2004 to 2009, from BD, 
USA, VERSATREK (Biomérieux, France) from 2009 to 2016 and 
BacT/ALERT 3D (Biomérieux, France) from 2016 to date.
Mycobacterial isolates were identified using a commercial 
PCR identification test (GenoType CM/AS, Hain, Germany), and 
those isolates that could not be identified with this technique 
were sent to the Mycobacteria reference laboratory (Centro 
Nacional de Microbiología, Majadahonda, Spain). Antimicrobial 
susceptibility test was performed for all mycobacterial isolates 
with the broth microdilution reference technique [16]. 
On one hand, clinical charts were evaluated according 
to a predefined protocol that includes demographics, 
evaluation of risk factors (respiratory syndromes, HIV 
infection, immunosuppressive drug treatment and presence 
of biomaterials), clinical syndrome, treatment and outcome. 
Criteria from the ATS [17] for interpretation of an isolate 
were followed to determine the clinical significance of each 
case. On the other hand, we considered a case of doubtful 
clinical significance when it presented with clinical signs of 
infection in the absence of other possible causes, and showed 
improvement after treatment with antimicrobial therapy, 
but did not fulfill the microbiological criteria. The Clinical 
Research Ethics Committee of our hospital approved the study 
(registration number EO137-18_FJD)
RESULTS
Growing of NPRGM was observed in 76 clinical samples of 
59 patients from January 1st 2004 to December 31st 2017.
Figure 2  Evolution of cases of infection caused by NPRGM (patients/year)
NPRGM: non-pigmented rapidly growing mycobacteria
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Case Year Sex Age Underlying diseases Syndrome Positive samples Acid-fast stain Therapy Species
1 2004 F 36 Chronic bronchopaty Dysphonia Laryngeal biopsy Positive IS+RI M. chelonae
2 2005 F 45 NO Mastitis Skin exudate Negative CI M. fortuitum
3 2005 M 55 Multiple myeloma Catheter infection Catheter exudate Positive AM+CI+CL M. chelonae
4 2006 F 30 Depressive syndrome Skin and soft tissue 
infection
Skin biopsy Negative CI M. fortuitum
5 2007 F 51 HIV, Burkitt lymphoma Disseminated infection Blood cultures Negative CL+CO M. fortuitum
6 2007 M 48 Multiple myeloma Catheter infection Catheter exudate Negative CO M. fortuitum
7 2008-2013 M 45 HIV, Chronic respiratory insufficiency Bronchiectasias Sputum Negative CL M. abscessus
8 2011 F 86 Lower eyelid myofibroblastic tumor Conjunctivitis Conjunctival exudate Not performed CL M. chelonae
9 2012-2014 F 56 Chronic obstructive pulmonary disease Bronchiectasias Bronchial lavage Negative LE M. abscessus
10 2012 F 80 NO Arthritis Bone prosthesis Negative CI+RI M. fortuitum
11 2012 F 62 Alpha1-antitrypsin deficiency Bronchiectasias Sputum Positive NO M. abscessus
12 2015 M 71 Chronic obstructive pulmonary disease Bronchiectasias Sputum Negative CI M. fortuitum
13 2015 F 49 Asthma Bronchiectasias Bronchial lavage Negative CI+CO M. fortuitum
compared to 30.8 % in a previous study [18]. This fact could 
be related to the increased number of respiratory tract isolates, 
probably due to the environmental nature of these bacteria. 
M. abscessus, M. chelonae and M. fortuitum have been usually 
associated with human diseases, while other members of the 
group are environmental isolates that cause human infections 
in rare cases [18-20]. M. porcinum has emerged in the last years 
as a species clearly related to human diseases, being involved 
in respiratory infections [21], but our only isolate has no role in 
the disease of this patient. Among other species, most clinically 
significant cases of M. mucogenicum isolates are involved in 
catheter-related infections [22]. M. peregrinum is a species 
included in the Mycobacterium fortuitum complex, but only a 
few cases of true infections have been reported, mainly related 
to surgical site infections and catheter-related infections [23]. 
M. arupense isolates have been related to pulmonary disease 
and osteoarticular infection [24-25]. In our series, all these 
species appeared to be colonizing organisms or contaminants, 
while the clinically relevant isolates belonged to the most 
common pathogens of this group: M. fortuitum, M. abscessus 
and M. chelonae.
According to the literature, the isolation of NPRGM has 
not a clear role in respiratory infection diseases such as chronic 
obstructive pulmonary disease (COPD) and bronchiectasis 
[19]. In these patients, the distinction between colonization 
and infection is a difficult clinical decision in most cases. M. 
abscessus is known to be a pathogen implicated in respiratory 
syndromes. It account for the majority of pulmonary infection 
cases in patients with underlying diseases like bronchiectasis, 
When we focus on the underlying diseases in the clinically 
significant group chronic respiratory disease (6 cases), presence 
of malignancy (2 cases) and human immunodeficiency virus 
(HIV) disease (2 cases) were detected. There was 1 case of 
surgical infection related to shoulder prosthesis. 
Acid-fast bacilli were detected in stains from samples in 
4 of the significant and doubtful cases (33.33%). There was a 
clinically significant case (conjunctival exudate) in which the 
acid-fast stain was not performed. Interestingly, 2 samples of 
the non-significant group were also acid-fast stain positive.
Regarding the therapeutic actions in the clinically 
significant group, all the patients were treated with 
antimicrobial therapy except the doubtful case. There were 
8 cases treated with monotherapy regimen (3 cases with 
ciprofloxacin, 2 cases with clarithromycin, 1 case with 
levofloxacin and 1 case with cotrimoxazol). Ciprofloxacin 
and clarithromycin were the mainly used antibiotics, either 
as monotherapy or in a combination antimicrobial regimen. 
In the implant-related infection it was necessary to remove 
the prosthesis in order to cure the infection. All the patients 
were cured, except 2 cases which are currently being under 
follow-up/control. One patient died due to other pathology. 
No resistances during therapy were detected.
DISCUSSION
NPRGM are usually considered environmental 
opportunistic pathogens. In our series we documented 
that only 20.34% of the isolates were clinically significant, 
Table 1 Characteristics of the cases of infection caused by NPRGM and the case with doubtful significance.
NPRGM: non-pigmented rapidly growing mycobacteria; M: Male; F: Female; NO: No disease/Not received; AM: Amikacin; CI: Ciprofloxacin; CL: Clarithromycin; CO: Cotrimoxazole; 
IS: Isoniazid; LE: Levofloxacin; RI: Rifampicin.
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biomaterials) is almost always related to the clinical syndrome. 
In order to avoid the failure of the treatment, an adequate 
microbiological identification and susceptibility test is needed, 
which would allow to choose a correct antimicrobial therapy 
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